-
Estimating the Future Burden of Unvaccinated Girls Against Human Papilloma Virus (HPV) in Europe: A Modeling Study
Sep 9, 2025, 16:22 PM -
Inequity in Public Healthcare Utilization Among Persons With Disabilities in Bangladesh: A Benefit Incidence Analysis
Sep 9, 2025, 16:22 PM -
AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy
Sep 9, 2025, 16:22 PM -
Economic and Organizational Impact of Subcutaneous Ocrelizumab in French Daily Hospitals
Sep 9, 2025, 16:22 PM -
Gaps in JCA Guidance for Systematic Literature Reviews: A Comparative Review with Cochrane, EUnetHTA, and Major HTA Agencies' Standards
Sep 9, 2025, 16:22 PM -
Budget Impact and Clinical Outcomes of Energy- and Nutrient-Dense Formulas in Pediatric Disease-Related Malnutrition: A Middle Eastern Analysis
Sep 9, 2025, 16:22 PM -
Preliminary Observational Analysis of Digital Health Platform Associated With Medical Cost Changes in Employer Population
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Iptacopan for Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With C5 Inhibitor in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
How Can Intravitreal Aflibercept 8 mg Impact Treatment Burden and Costs in European Patients With Diabetic Macular Edema? From Clinical Trials to Clinical Practice
Sep 9, 2025, 16:22 PM -
Comparative Effectiveness of Second-Line Antidiabetic Medications on the Risk of Major Adverse Cardiovascular Events: A Real-World Study in China
Sep 9, 2025, 16:22 PM -
Early Adoption of New Combination Biologic Therapy Enabled by Enhanced Diagnostic Accuracy in Inflammatory Bowel Disease (IBD) Can Be a Budget-Neutral Approach: A Budget Impact Analysis in Italy
Sep 9, 2025, 16:22 PM -
Persistence With Osteoporosis Medication Treatments Among Chinese Patients With Osteoporosis: A Retrospective Cohort Study
Sep 9, 2025, 16:22 PM -
Cost Effectiveness and Budget Impact Analysis of Benralizumab for Treating Severe Uncontrolled Eosinophilic Asthma in Egypt
Sep 9, 2025, 16:22 PM -
Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis
Sep 9, 2025, 16:22 PM -
Impact of Resmetirom on Liver Transplant Demand and Outcomes in US Patients With MASH
Sep 9, 2025, 16:22 PM -
What Has Worked Well in Fabry Disease? An HTA Landscape Assessment Study
Sep 9, 2025, 16:22 PM -
Economic Impact of Poison Control Center Interventions on Hospitalization Costs in Algeria: A Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Implementation and Outcomes of Managed Entry Agreements Across the Nordic Region
Sep 9, 2025, 16:22 PM -
Evaluating Patient Preferences for Clinical Trial Endpoints in Early Stage Cancer: A Discrete Choice Experiment in Canada
Sep 9, 2025, 16:22 PM -
From Policy to Practice: Are Larger Member States Leading the Way for Joint Clinical Assessments?
Sep 9, 2025, 16:22 PM
